Extracellular Vesicle-Based Drug Delivery Systems
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: closed (31 March 2024) | Viewed by 3446
Special Issue Editor
Special Issue Information
Dear Colleagues,
This Special Issue of the journal Pharmaceutics will be devoted to the presentation of recent advances in the study of extracellular vesicles for drug delivery. In the most recent decade, extracellular vesicles (EVs) have emerged as a key mediator of cell-to-cell communication, and their significance in a range of physiological processes has inspired researchers to exploit EVs as novel therapeutics. In particular, the unique characteristics of EVs when interacting with other cells provide an exceptional benefit that can be internalized into target cells. Therefore, with such advantages, EVs have been hugely studied as a promising candidate for developing and delivering innate cargo, drugs, and nucleic acids.
Topics of interest for this Special Issue include EV-based drug delivery systems for targeted therapy, gene therapy, regenerative therapy, and related concepts. Additionally, applications of EVs on targeted diagnosis and discovery of new characteristics of EVs as a drug delivery and cargo delivery system will be covered.
Dr. Wooram Um
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- extracellular vesicles
- exosome
- drug delivery
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
